Evidence map›Paper›PMID 27256997›Full record

ArticleBMJ case reports2016

Lethargy and vision loss: successful management of rhinocerebral mucormycosis.

Ramzi Mulki, Muhammad Masab, Glenn Eiger, Sarah Perloff

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Rhino-Orbito-Cerebral Mucormycosis: An Audit.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2022
    Article
  4. Article
  5. Case Report:Frontiers in medicine · 2021
    Article
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ramzi MulkiEinstein Medical Center, Philadelphia, Pennsylvania, USA.
Muhammad MasabEinstein Medical Center, Philadelphia, Pennsylvania, USA.
Glenn EigerEinstein Medical Center, Philadelphia, Pennsylvania, USA.
Sarah PerloffDivision of Infectious Diseases, Einstein Medical Center, Philadelphia, Pennsylvania, USA.
Einstein Medical Center Philadelphia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rhinocerebral mucormycosis (RCM) is an angioinvasive fungal infection most often caused by Rhizopus oryzae It is usually associated with an underlying risk factor and is associated with a poor prognosis. There are no consensus guidelines on the optimal management of this aggressive disease; most management decisions are based on case reports and expert opinion. We report a successfully managed case of RCM in an insulin-dependent diabetic, initially presenting with a change in mental status, rapidly progressing to complete right eye blindness and ophthalmoplegia and complicated by multiple cerebral infarctions and abscesses. We describe the diagnostic approach and various therapeutic interventions undertaken to successfully manage our patient.

Indexed as

Antifungal AgentsBlindnessBrainBrain AbscessDiabetes Mellitus, Type 1Diabetic KetoacidosisFemaleHumansLethargyMucormycosisParanasal Sinus DiseasesRhizopusRisk FactorsYoung AdultAntifungal Agents

Identifiers

PMID27256997
PMCPMC4904383
OpenAlexW2416394235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.